A novel EGFR-TKI inhibitor (cAMP-H3BO3complex) combined with thermal therapy is a promising strategy to improve lung cancer treatment outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel EGFR-TKI inhibitor (cAMP-H3BO3complex) combined with thermal therapy is a promising strategy to improve lung cancer treatment outcomes

Published:2017-05-05 Issue:34 Volume:8 Page:56327-56337
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Tong Yongpeng¹,Huang Chunliu²,Zhang Junfang³

Affiliation:

1. College of Physics and Energy, Shenzhen University, Shenzhen, 518060, China

2. School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, China

3. School of Medicine, Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518060, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thymoquinone, as a Novel Therapeutic Candidate of Cancers;Pharmaceuticals;2021-04-16

2. Role of PARP1-mediated autophagy in EGFR-TKI resistance in non-small cell lung cancer;Scientific Reports;2020-12

3. Near-infrared/pH dual-responsive nanocomplexes for targeted imaging and chemo/gene/photothermal tri-therapies of non-small cell lung cancer;Acta Biomaterialia;2020-04

4. Study of ATP borate ester effects on cell sensitization to radiation emitted by a nuclear reactor;Nuclear Science and Techniques;2019-12-19

5. Inhibiting two cellular mutant epidermal growth factor receptor tyrosine kinases by addressing computationally assessed crystal ligand pockets;Future Medicinal Chemistry;2019-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP